Clinical trial
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal…
NCT00037180 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00037180 |
|---|---|
| Title | For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy |
| Official title | Phase II, Randomized, Double-Blind, Multicenter Trial Of Celecoxib Vs Placebo For The Prevention Of Diarrhea Associated With CPT-11/5fu/LV Chemotherapy In Patients With Previously Untreated Metastatic Colorectal Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis, Colorectal Neoplasms |
| Intervention type | Drug |
| Interventions | Celecoxib, Irinotecan, 5-fluorouracil, Leucovorin |
| Enrollment | 212 |
| Start date | Apr 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | May 17, 2002 |
| Last update posted | Sep 29, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: